Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu
- PMID: 11840334
- DOI: 10.1038/sj.onc.1205146
Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu
Abstract
The conditional expression of activated HER2/neu gene under its endogenous promoter in the mammary epithelium of the mouse results in accelerated lobular development and focal mammary tumors. Carcinogenesis, however, requires amplification and considerably increased expression levels of oncogenic neu. Deducing from the multiple genetic aberrations required for human breast cancer to develop, we hypothesized that in addition to the over-expression of an activated HER2/neu, secondary aberrations would occur. We have therefore conducted a genomic screen for chromosomal imbalances and translocations using comparative genomic hybridization and spectral karyotyping. The results reveal a moderate degree of chromosomal instability and micronuclei formation in short-term cultures established from primary tumors. Genomic instability appears to be linked to the amplification of functional centrosomes, a phenomenon that we frequently observed in other tumor types. Seventy per cent of the tumors revealed genomic amplification of HER2/neu, often in the form of double minute chromosomes, which correlated with recurring loss of mouse chromosome 4D-E, a region that is orthologous to distal human chromosome 1p. It is likely that this region contains putative tumor suppressor genes whose inactivation is required for tumor formation in this model of human breast cancer.
Similar articles
-
Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.Oncogene. 2002 Aug 1;21(33):5097-107. doi: 10.1038/sj.onc.1205636. Oncogene. 2002. PMID: 12140760
-
A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.Genes Chromosomes Cancer. 1999 Jul;25(3):251-60. Genes Chromosomes Cancer. 1999. PMID: 10379871
-
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.Cancer Res. 2006 May 1;66(9):4672-80. doi: 10.1158/0008-5472.CAN-05-2909. Cancer Res. 2006. PMID: 16651418
-
Oncogenic activating mutations in the neu/erbB-2 oncogene are involved in the induction of mammary tumors.Ann N Y Acad Sci. 1999;889:45-51. doi: 10.1111/j.1749-6632.1999.tb08722.x. Ann N Y Acad Sci. 1999. PMID: 10668481 Review.
-
Emerging roles of centrosomal amplification and genomic instability in cancer.Front Biosci. 2005 Jan 1;10:728-42. doi: 10.2741/1567. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15569613 Review.
Cited by
-
Met promotes the formation of double minute chromosomes induced by Sei-1 in NIH-3T3 murine fibroblasts.Onco_target. 2016 Aug 30;7(35):56664-56675. doi: 10.18632/onco_target.10994. Onco_target. 2016. PMID: 27494853 Free PMC article.
-
Identification of Jun loss promotes resistance to histone deacetylase inhibitor entinostat through Myc signaling in luminal breast cancer.Genome Med. 2018 Nov 30;10(1):86. doi: 10.1186/s13073-018-0597-3. Genome Med. 2018. PMID: 30497520 Free PMC article.
-
Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model.Front Genet. 2018 Jan 23;9:6. doi: 10.3389/fgene.2018.00006. eCollection 2018. Front Genet. 2018. PMID: 29410677 Free PMC article.
-
An EGR2/CITED1 transcription factor complex and the 14-3-3sigma tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer.Mol Cell Biol. 2007 Dec;27(24):8648-57. doi: 10.1128/MCB.00866-07. Epub 2007 Oct 15. Mol Cell Biol. 2007. PMID: 17938205 Free PMC article.
-
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2778-83. doi: 10.1073/pnas.1018862108. Epub 2011 Jun 1. Proc Natl Acad Sci U S A. 2012. PMID: 21633010 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous